Many people have cured their cancer by taking a veterinarian drug known as fenbendazole. This anthelmintic is prescribed to dogs as part of the Joe Tippens Protocol, at 222 mg daily (or 1 gram per day of Panacur C).
Indian scientists have found that this broad-spectrum anti-parasitic drug has potential as an anti-cancer drug. It suppresses the growth of cancer cells by interfering with microtubules, which provide structure to all cells.
Fenbendazole is part of the benzimidazole family of broad-spectrum anthelmintics and has been used for decades as an anthelmintic in animals. It has a high safety margin and is very well tolerated by most species. It is also one of the anthelmintics known to have activity against some of the parasites that can cause gastrointestinal upset in humans (Alaria spp., Giardia lamblia, Heterobilharzia americana, and Platynosomum fastosum).
In mammals, fenbendazole is extensively metabolized following oral administration and its metabolites predominate in plasma and tissues. However, intranasal administration allows for rapid absorption through the olfactory and trigeminal nerve pathways, bypassing liver metabolism. This results in a higher level of drug exposure than is achieved with the oral route.
The fungicide fenbendazole has been shown to be safe for use in humans in a randomized placebo-controlled first-in-human single-dose escalation study. Oxifendazole, an activated metabolite of fenbendazole, has been studied in several human studies and is well-tolerated at the highest recommended doses. No serious adverse reactions or deaths have been reported.
The bactericide fenbendazole has also been tested in swine, with no serious adverse effects reported. Safe-Guard AquaSol, a suspension concentrate containing fenbendazole, has a low toxicity profile and is well-tolerated by most swine, including nursing piglets. It is indicated in swine for the control of lungworms (Metastrongylus apri, M. pudendotectus) and stomach worms (Hyostrongylus rubidus, M. sarcomata, Trichuris suis) and nodular worms (Stephanurus dentatus).
Fenbendazole is a benzimide and has a long track record of safe use in humans. It is widely used as an antiparasitic agent for gastrointestinal parasites (pinworms, roundworms, hookworms and whipworms), and other animal worms, including tapeworms (Hydrogenidium japonicum and Taenia solium). It is also a well-established anthelmintic drug in horses and cats. It is a well-tolerated drug with minimal side effects, except for some stomach upset.
Despite the fact that there is no evidence to support fenbendazole’s ability to cure cancer, it is still being promoted by some people online. Some of the information is spread through social media channels, like TikTok and Facebook.
In a video, Jones shared Joe Tippens’ story in which the man claimed to have been healed of his stage four colon cancer by taking fenbendazole along with other established treatments.
He then cited a few studies, but none of the papers included in the references were peer-reviewed. In addition, there is no evidence to suggest that fenbendazole can prevent cancer from recurrence.
Scientists who studied human non-small cell lung cancer cells in vitro found that fenbendazole caused moderate microtubule disruption, increased p53 tumour suppressor activity and interfered with glucose uptake by cancer cells. These results are similar to those observed with cytotoxic anticancer agents, such as vinca alkaloids and taxanes. These findings were published in the journal Scientific Reports.
Fenbendazole (trade names Panacur and Safe-Guard) is a broad-spectrum benzimidazole carbamate antiparasitic drug used in many animal species. The drug is well tolerated in most species and exhibits a high safety margin. Its toxicity in experimental animals is generally very low. Hence, it is a good candidate for repurposing as an anticancer drug.
According to some research, fenbendazole interferes with the formation of microtubules, which are the protein scaffolding that gives cells their shape and structure. In addition, the drug can disrupt glucose uptake by cancer cells, reducing their energy supply and causing them to die. However, there isn’t enough evidence from randomized clinical trials to show that fenbendazole cures cancer in humans.
In a model of allergic airway disease induced by ovalbumin exposure, fenbendazole inhibited the production of Th2-derived cytokines and goblet cells in the lungs. The drug also reduced the concentration of ovalbumin-specific IgG1 antibody in bronchoalveolar lavage fluid.
The Joe Tippens Protocol has been gaining popularity after some advanced cancer patients claimed that fenbendazole helped them survive their diagnoses. The protocol involves taking a variety of supplements and medications, including fenbendazole. However, the medical community is skeptical of the claims. The FDA told Full Fact that there is insufficient proof that the drug can treat cancer, and that it hasn’t been tested in randomized clinical trials.
Fenbendazole is an FDA-approved medication for treating parasites and worms in animals such as dogs, cats, cattle, horses, sheep, and goats (common brand names include Panacur and Safe-Guard). It is also used by humans in a method of cancer treatment known as the Joe Tippens Protocol. While anthelmintic drugs like fenbendazole are being investigated as possible cancer treatments in humans, there is no scientific evidence that they can cure cancer.
Researchers have found that some antiparasitic medications, such as fenbendazole, may kill cancer cells by interfering with the formation of microtubules. Microtubules are part of a protein scaffolding inside cells that establishes structure and shape. They are also involved in cell division, which is how chromosomes are separated evenly during mitosis. Drugs that disrupt the function of microtubules can block important processes that are needed for cellular activity and growth, which is why they are classified as cytotoxic anticancer agents.
However, the claims that fenbendazole can kill cancer are controversial and unproven. There are many other factors that could contribute to a person’s remission from cancer, including standard of care treatments and the patient’s diet, lifestyle, and other natural supplements and herbs. Further, there are no randomized controlled trials that prove that fenbendazole, or any other antiparasitic medication, can kill cancer. Therefore, it is important to consult a medical professional before starting any alternative cancer treatments. fenbendazole for humans